For instance, in type II diabetes, the aberrant activity of the NLRP3-inflammasome complex leads to IL1β secretion and caspase-1 activation that impair pancreatic β-cell function, adipocyte function and insulin sensitivity, promoting obesity and insulin resistance [42,43]. This evidence concerns the gene NLRP3 and obesity disorder.